Israeli company's COVID-19 drug shows promise in late-stage coronavirus treatment
November 23, 2021 at 11:33 AM EST
FIRST ON FOX: An Israeli public company says it developed the "only cure for late-stage COVID" and said that the results of its phase II clinical trial, disclosed first to Fox News, revealed that patients suffering from severe cases of COVID-19 had a 94% survival rate after being treated with the drug.
